Guidelines for the Treatment of People with Sickle Cell Disease

Scientific Publications and Reports


	Guidelines for the Treatment of People with Sickle Cell Disease Written by members of the Sickle Cell Advisory Committee (SCAC) of GENES (The Genetic Network of New York, Puerto Rico and the Virgin Islands) with support from the U.S. Health Resources and Services Administration (HRSA). These guidelines are a consensus document developed by health care providers who have both expertise and experience in working with sickle cell patients. Consumers provided significant input. Topics include: Newborn screening Genetic testing and counseling Social work Nursing concerns Routine health maintenance Growth and development Emergency treatments Pain Infections Limp Osteomyelitis Splenic dysfunction and sequestration Acute anemia Chest pain and acute chest syndrome Obstructice sleep apnea Strokes Transfusion therapy Surgery and anesthesia Heart disease Eye problems Pregnancy Priapism Avascular necrosis Hepatic disorders and hyperbilirubinemia Urinary tract disorders Leg ulcers For more information, contact: Katharine B. Harris, M.B.A. New York State Sickle Cell Program Coordinator Wadsworth Center, Room E-297 P.O. Box 509, Albany, NY 12201 (518) 474-7148

	© 2008 March of Dimes Foundation. All rights reserved. The March of Dimes is a not-for-profit organization recognized as tax-exempt under Internal Revenue Code section 501(c)(3). Our mission is to improve the health of babies by preventing birth defects, premature birth, and infant mortality.